-
Bagnaia scorches to Czech MotoGP sprint victory, Bezzecchi crashes
-
Iran says Hormuz closed again after Israel strikes Lebanon
-
Trump escalates spat with Italy’s Meloni over G7 photo claim
-
New Zealand set England record 463 to win second Test
-
Driver killed, 28 in hospital as UK train collision probed
-
Diplomats hold US-Iran preparatory discussions at Swiss retreat
-
New Zealand pile on the runs to leave England facing record chase in 2nd Test
-
Shahidi hits ton but India bowl out Afghanistan for 218
-
Court bans Spanish PM's wife from leaving country
-
Israel strikes south Lebanon despite truce announced with Hezbollah
-
Japan's Ogura smashes own track record to take Czech MotoGP pole
-
Hurricanes blow away Chiefs in record-breaking Super Rugby final
-
Germany meet Ivory Coast in high-stakes World Cup clash, Sweden face Dutch
-
Ancient Greek theatre revives legendary Callas opera Medea
-
Indian guru urges broader view of yoga
-
Portugal's unofficial exorcism fever worries Church
-
Paraguay's Almiron sent off under new FIFA 'mouth-covering' rule
-
Ancelotti hails 'complete game' as Brazil sink Haiti at World Cup
-
Tunisia ask how Sweden World Cup star Ayari slipped its net
-
Scotland remain bullish despite Morocco World Cup setback
-
USA down Australia to reach World Cup knockout rounds, Brazil swat Haiti
-
Brazil cruise past Haiti to re-ignite World Cup campaign
-
Australia detects first case of contagious H5 bird flu
-
Scheffler career Slam chances blowing in Shinnecock winds
-
Iran's treatment at World Cup 'a dark point' for football: official
-
McIlroy seven back but likes his chances at US Open
-
Nagelsmann eyes same German lineup against I. Coast after Curacao trouncing
-
Clark leads US Open by four with major champs in the hunt
-
Saibari early strike gives Morocco World Cup win over Scotland
-
Archaeologists discover 'never before seen' pre-Hispanic ruins in Mexico
-
Pochettino backs 'high IQ' players to block out World Cup hype
-
James Burrows, prolific innovator in US TV comedies, dead at 85
-
Douglass breaks 50m free world record at Indy Pro Swim
-
World Cup warning with Sweden star Isak 'getting stronger and stronger'
-
'Like China': Cubans welcome reforms but exiles remain skeptical
-
Tunisia coach says 'I am no wizard' after World Cup SOS call
-
USA down Australia to reach World Cup knockout rounds
-
USA beat Australia 2-0 to reach World Cup knockouts
-
Imperious Dupont guides record-breaking Toulouse to Top 14 final
-
Qatar-gifted Air Force One replacement unveiled
-
Venezuelan opposition figure heads to US after transition talks
-
Niemann fires 65 at US Open after upsetting two-shot penalty
-
Canada star Kone to miss rest of World Cup after surgery: team
-
Spain's Yamal says 'too soon' to play full match at World Cup
-
Confident Fitzpatrick makes a run at another US Open title
-
Neymar? He is working remotely at the World Cup, jokes Lula
-
England captain Stokes strikes for Durham as Test recall looms
-
Three-time Stanley Cup champion Toews retires
-
Clark wants to win back fans as well as US Open title
-
Japan wary of fired up and wounded Tunisia for World Cup landmark game
US panel weighs authorizing Covid vaccines for youngest children
After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.
Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.
Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."
Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.
Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.
They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.
Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.
But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.
There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.
White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.
Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.
Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.
Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.
Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."
E.Schubert--BTB